Fertility app targeting millennial women hits iOS devices
NEW YORK — The Bump, a media company targeting millennial parents, announced the launch of Shine Period and Fertility Tracker app for iPhone on Friday. Shine's algorithm was built in partnership with fertility experts at Reproductive Medical Associates of New York and the app adapts to a user's personal needs of trying to avoid pregnancy or trying to conceive by offering personalized content for each experience.
Complete with articles, data-driven tips and interactive polls, Shine simplifies the process of period and fertility tracking with a fresh, intuitive design and experience made specifically for the millennial woman, the company said. Applying user-inputted data, Shine learns the unique patterns of each woman's menstrual cycle and predicts when she can expect to be fertile and on her period. It provides easy-to-use tools to record symptoms, moods, sexual activity, basal body temperature and cervical fluid. Through clear data visualizations and graphics, users learn how their body is impacted by their menstruation and ovulation.
“We're thrilled to extend The Bump platform to support women and their personal health, whether simply tracking their period or trying to conceive, with one of the simplest apps in the fertility and trying to conceive category,” said Julia Wang, site director of The Bump. “No other period and fertility tracking app offers the amount of personal health and trying to conceive content in a real, tell-it-like-it-is voice, which women have come to love on The Bump.”
Shine gives women the power to take charge of their health by providing timely information about their cycle and fertility each day, as well as collecting and saving historical data related to their cycle. The app offers content and recommendations personalized to each woman's cycle, tracking preferences and interests in an easy-to-use and modern mobile experience.
5 states still seeing obesity rates on the rise
WASHINGTON — U.S. adult obesity rates remained mostly steady ― but high ― this past year, increasing in Kansas, Minnesota, New Mexico, Ohio and Utah and remaining stable in the rest of the states, according to a new report from the Trust for America's Health and the Robert Wood Johnson Foundation released Monday.
Arkansas had the highest adult obesity rate at 35.9% while Colorado had the lowest at 21.3%. The 12th annual report found that rates of obesity now exceed 35% in three states (Arkansas, West Virginia and Mississippi), are at or above 30% in 22 states and are not below 21% in any. In 1980, no state had a rate above 15%, and in 1991, no state had a rate above 20. Now, nationally, more than 30% of adults, nearly 17% of 2 to 19 year olds and more than 8% of children ages 2 to 5 are obese.
Obesity puts some 78 million Americans at an increased risk for a range of health problems, including heart disease, diabetes and cancer.
“Efforts to prevent and reduce obesity over the past decade have made a difference. Stabilizing rates is an accomplishment. However, given the continued high rates, it isn't time to celebrate,” stated Jeffrey Levi, executive director of TFAH. “We've learned that if we invest in effective programs, we can see signs of progress. But, we still haven't invested enough to really tip the scales yet.”
Other key findings from the State of Obesity report include:
- Seven of the 10 states with the highest rates of obesity are in the South and nine of the 10 states with the highest rates of diabetes are in the South. Diabetes rates increased in eight states – Colorado, Hawaii, Kansas, Massachusetts, Missouri, Montana, Ohio and Pennsylvania;
- Nationally, obesity rates are 38% higher among Blacks than Whites; and more than 26% higher among Latinos than Whites. (Obesity rates for Blacks: 47.8%; Latinos: 42.5%; and Whites: 32.6%.);
- Obesity rates are 26% higher among middle-age adults than among younger adults ― rates rise from 30% of 20- to 39- year olds to nearly 40% of 40- to 59-year-olds; and
- More than 6% of adults are severely obese — more than a 125% increase in the past two decades. Around 5% of children are already severely obese by the ages of 6 to 11.
Camber Consumer Care launches store-brand Allegra
PISCATAWAY, N.J. — Camber Consumer Care recently launched a store-brand version of Allegra (fexofenadine hydrochloride, 180 mg), the company announced.
Allegra tablets had annual sales of approximately $60 million, based on IMS and IRI data for the 12 months ended June 2015.
Fexofenadine HCI Tablets are used to treat the symptoms of seasonal allergies and hay fever in adults and children and are available from Camber in both private label and control brands in 5- and 15-count blister packs and 30-, 45-, 60-, 90-, 180- and 500-count bottles.
Loading Post Please Wait...